Key result
Dominant-negative G alpha 12 and 13 strongly inhibit receptor-mediated smooth muscle contraction.
Receptor-induced vascular smooth muscle cell contraction is mediated by dual regulation of myosin light chain (MLC(20)) phosphorylation through Ca(2+)-dependent stimulation of myosin light chain kinase and Rho/Rho-kinase-mediated inhibition of myosin phosphatase. Although myosin light chain kinase regulation is initiated by the coupling of receptors to G proteins of the G(q) family, G(q) and G(11), it is not known how receptors regulate the Rho/Rho-kinase-mediated pathway. In vascular smooth muscle cells, receptor-mediated MLC(20) phosphorylation and cell contraction was blocked by inhibitors of each of the pathways. Receptors of various vasocontractors were found to couple to G(q)/G(11) and G(12)/G(13), and constitutively active forms of G alpha(12) and G alpha(13) induced a pronounced contraction of vascular smooth muscle cells that could be blocked by C3 exoenzyme, by inhibition of Rho-kinase, and by stable analogues of cGMP and cAMP. Receptor-mediated smooth muscle cell contraction was strongly inhibited by dominant-negative forms of G alpha(12) and G alpha(13). These data indicate that a G(12)/G(13)-mediated Rho/Rho-kinase-dependent pathway operates in smooth muscle cells and that dual regulation of MLC(20) phosphorylation by vasocontractors is initiated by the dual coupling of their receptors to G proteins of the G(q) and G(12) families.
No takes yet. Share an insight, caveat, or question.
Gohla et al. (2000) studied this question. Receptor-induced G(12)/G(13) activation was evaluated on Vascular smooth muscle cell contraction and MLC(20) phosphorylation. Dominant-negative forms of G alpha(12) and G alpha(13) strongly inhibited receptor-mediated smooth muscle cell contraction, indicating a necessary dual coupling pathway alongside G(q) proteins.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: